Search filters

List of works by Genevieve M Weir

A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.

scientific article published on 23 July 2010

A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.

scientific article

Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.

scientific article published on 4 November 2014

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

scientific article

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein

scientific article published on 12 June 2020

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

scientific article published on August 3, 2012

Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy

scientific article published on 27 June 2020

Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines

scientific article published on 05 August 2011

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response

scientific article

Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models

Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy

scientific article published on 29 November 2020

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

scientific article published on 7 June 2007

Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal spore inhalation challenge

scientific article published on 08 February 2019

Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax

scientific article published on 23 April 2007

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

scientific article published on 21 September 2017